As of 2024-12-12, the EV/EBITDA ratio of Erytech Pharma SA (ERYP.PA) is 0.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ERYP.PA's latest enterprise value is -11.85 mil EUR. ERYP.PA's TTM EBITDA according to its financial statements is -23.57 mil EUR. Dividing these 2 quantities gives us the above ERYP.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 7.0x - 9.1x | 8.0x |
Forward P/E multiples | 9.4x - 10.4x | 10.0x |
Fair Price | (7.34) - (7.08) | (6.98) |
Upside | -1571.9% - -1519.0% | -1497.9% |
Date | EV/EBITDA |